Discoid lupus treatment
The researchers found that 12 of the 13 patients who received Raptiva responded well, with 11 showing improvement rated as very good or excellent. Patients with discoid lupus have unusual antibodies in their blood that are targeted against their own body tissues.
There is a branded drug on the market, Plaquenil, which may help improve the condition of discoid lesions. However, patients will be required to take yearly eye exams to ensure the prevention of retina damage. In fact, six month follow-ups are often recommended.
This Also this is an early report of findings in patients who were treated in a clinic. It is not a scientific study with a comparison group of patients who do not receive the treatment, and where the study is “blinded” so that the patients and the physicians evaluating them would not know if they received Raptiva or not.
Sorry, comments for this entry are closed at this time.